{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:35:02Z","timestamp":1761561302774},"reference-count":37,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Disease in Childhood"],"published-print":{"date-parts":[[1989,4,1]]},"DOI":"10.1136\/adc.64.4.535","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T22:13:07Z","timestamp":1229983987000},"page":"535-540","source":"Crossref","is-referenced-by-count":17,"title":["Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease."],"prefix":"10.1136","volume":"64","author":[{"given":"Q","family":"Mok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Underhill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Wonke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Aldouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kelsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Jefferies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-3476(86)80995-7","article-title":"Low risk of hepatitis B from blood transfusions in thalassemic patients in Connecticut","volume":"108","author":"Pearson, H.A.; Wood, C.; Andiman, W.; Bore, J.; Rink, L.","year":"1986","unstructured":"Pearson HA, Wood C, Andiman W, Bore J, Rink L. Low risk of hepatitis B from blood transfusions in thalassemic patients in Connecticut. J Pediatr 1986;108:252-3.","journal-title":"J Pediatr"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1136\/bmj.288.6433.1804","article-title":"Hepatitis B virus infection in thalassaemia major treated in London and Athens","volume":"228","author":"Mieli-Vergani, G.; Vergani, D.; White, Y.","year":"1984","unstructured":"Mieli-Vergani G, Vergani D, White Y, et al. Hepatitis B virus infection in thalassaemia major treated in London and Athens. Br Med J 1984;228:1804.","journal-title":"Br Med J"},{"key":"ref_3","article-title":"Vaccine against viral hepatitis and process","author":"Blumberg, B.S.; Millman, I.","year":"1972","unstructured":"Blumberg BS, Millman I. Vaccine against viral hepatitis and process. Patent No 36 36 191. Washington DC: United States Patent Office, 1972."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM198010093031501","article-title":"Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high risk population in the United States","volume":"303","author":"Szmuness, W.; Stevens, C.E.; Harley, E.J.","year":"1980","unstructured":"Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high risk population in the United States. N Engl J Med 1980;303: 833-41.","journal-title":"N Engl J Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jmv.1890080206","article-title":"The immune response of healthy adults to a reduced dose of hepatitis B vaccine","volume":"8","author":"Szmuness, W.; Stevens, C.E.; Harley, E.J.","year":"1981","unstructured":"Szmuness W, Stevens CE, Harley EJ, et al. The immune response of healthy adults to a reduced dose of hepatitis B vaccine. J Med Virol 1981;8:123-9.","journal-title":"J Med Virol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jmv.1890080205","article-title":"Immunogenic effect of inactivated hepatitis B vaccine: comparison of 20, ug and 40 pg doses","volume":"8","author":"Krugman, S.; HP, Jr, Holley; Davidson, M.; Simberkoff, M.S.; Matsaniatis, N.","year":"1981","unstructured":"Krugman S, Holley HP Jr, Davidson M, Simberkoff MS, Matsaniatis N. Immunogenic effect of inactivated hepatitis B vaccine: comparison of 20,ug and 40 pg doses. J Med Virol 1981;8: 119-21.","journal-title":"J Med Virol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-97-3-362","article-title":"The prevention of hepatitis B with vaccine: report of Centers for Disease Control multicentre efficacy trial among homosexual men","volume":"97","author":"Francis, D.P.; Hadler, S.C.; Thompson, S.E.","year":"1982","unstructured":"Francis DP, Hadler SC, Thompson SE, et al. The prevention of hepatitis B with vaccine: report of Centers for Disease Control multicentre efficacy trial among homosexual men. Ann Intern Med 1982;97:362-6.","journal-title":"Ann Intern Med"},{"key":"ref_8","first-page":"\"53","article-title":"Reduction of the dose of hepatitis B vaccine","volume":"7","author":"Papaevangelou, G.; Roumeliitou-Karayannis, A.; Vissoulis, C.H.","year":"1983","unstructured":"Papaevangelou G, Roumeliitou-Karayannis A, Vissoulis CH, et al. Reduction of the dose of hepatitis B vaccine. J Infect 1983;7(suppl):53-5. 9Hepatitis B virus vaccine safety: report of an interagency group. MMWR 1982;31:465-7.","journal-title":"J Infect; B virus vaccine safety: report of an interagency group"},{"key":"ref_9","first-page":"1454","article-title":"Intradermal hepatitis B virus vaccine: immunogenicity and side effects in adults","volume":"ii:","year":"1983","unstructured":"Intradermal hepatitis B virus vaccine: immunogenicity and side effects in adults. Lancet 1983;ii:1454-6.","journal-title":"Lancet"},{"key":"ref_10","first-page":"568","article-title":"Antibody responses and skin reactivity after intradermal hepatitis B virus vaccine","volume":"i:","author":"Zoulek, G.; Lorbeer, B.; Jilg, W.; Deinhardt, F.","year":"1984","unstructured":"Zoulek G, Lorbeer B, Jilg W, Deinhardt F. Antibody responses and skin reactivity after intradermal hepatitis B virus vaccine. Lancet 1984;i:568.","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jmv.1890140105","article-title":"Evaluation of a reduced dose of hepatitis B vaccine administered intradermally","volume":"14","author":"Zoulek, G.; Lorbeer, B.; Jilg, W.; Deinhardt, F.","year":"1984","unstructured":"Zoulek G, Lorbeer B, Jilg W, Deinhardt F. Evaluation of a reduced dose of hepatitis B vaccine administered intradermally. J Med Virol 1984;14:27-32.","journal-title":"J Med Virol"},{"key":"ref_12","first-page":"694","article-title":"Immunogenicity and reactogenicity of low-dose intradermally administered heptavax-B-vaccine in man","volume-title":"hepatitis and liver disease","author":"Redfield, R.R.; Innis, B.L.; Cannon, H.G.; McNair-Scott, R.; Bancroft, W.H.","year":"1984","unstructured":"Redfield RR, Innis BL, Cannon HG, McNair-Scott R, Bancroft WH. Immunogenicity and reactogenicity of low-dose intradermally administered heptavax-B-vaccine in man. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral hepatitis and liver disease. Orlando: Grune and Stratton, 1984:694-5."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1001\/jama.1985.03360220069031","article-title":"Clinical evaluation of low dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy","volume":"254","author":"Redfield, R.R.; Innis, B.L.; McNair-Scott, R.; Cannon, H.G.; Bancroft, W.H.","year":"1985","unstructured":"Redfield RR, Innis BL, McNair-Scott R, Cannon HG, Bancroft WH. Clinical evaluation of low dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy. JAMA 1985;254:3203-6.","journal-title":"JAMA"},{"key":"ref_14","first-page":"153","article-title":"Intradermal vaccination against hepatitis B in Immanuel Hospital personnel-a preliminary report","volume":"15","author":"Prasetya, E.; Linggadjaja, W.; Syambali, R.; Kusumo, S.; Dharmesetyawan, D.F.; Rahardja, U.","year":"1986","unstructured":"Prasetya E, Linggadjaja W, Syambali R, Kusumo S, Dharmesetyawan DF, Rahardja U. Intradermal vaccination against hepatitis B in Immanuel Hospital personnel-a preliminary report. Ann Acad Med Singapore 1986;15:153-7.","journal-title":"Ann Acad Med Singapore"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/jcp.31.6.546","article-title":"Serum immunoglobulin concentrations before and after splenectomy in patients with homozygous,3 thalassaemia","volume":"31","year":"1978","unstructured":"Constantoulakis M, Trichopoulos D, Argoustaki 0, Economidou J. Serum immunoglobulin concentrations before and after splenectomy in patients with homozygous,3 thalassaemia. J Clin Pathol 1978;31:546-50.","journal-title":"J Clin Pathol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/jcp.32.10.1045","article-title":"Changes in T and B blood lymphocytes after splenectomy","volume":"32","author":"Millard, R.E.; Banarjee, D.K.","year":"1979","unstructured":"Millard RE, Banarjee DK. Changes in T and B blood lymphocytes after splenectomy. J Clin Pathol 1979;32:1045-9.","journal-title":"J Clin Pathol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1542\/peds.60.3.349","article-title":"Defects of neutrophil chemotaxis and random migration in thalassemia major","volume":"60","author":"Khan, A.J.; Lee, C.K.; Wolff, J.A.; Chang, H.; Khan, P.; Evans, H.E.","year":"1977","unstructured":"Khan AJ, Lee CK, Wolff JA, Chang H, Khan P, Evans HE. Defects of neutrophil chemotaxis and random migration in thalassemia major. Pediatrics 1977;60:349-51.","journal-title":"Pediatrics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00043426-198406020-00019","article-title":"Defective function of the peripheral blood neutrophils in thalassemia major","volume":"6","author":"Giuntoli, J.M.T.; Estevez, M.E.; Sen, L.; Penalver, J.A.","year":"1984","unstructured":"Giuntoli JMT, Estevez ME, Sen L, Penalver JA. Defective function of the peripheral blood neutrophils in thalassemia major. Am J Pediatr Hematol Oncol 1984;6:215-16.","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/bmj.290.6461.14","article-title":"Impaired antipneumococcal antibody production in patients without spleens","volume":"290","author":"F, Di Padova; M, Durig; F, Harder; C, Di Padova; C, Zanussi","year":"1985","unstructured":"Di Padova F, Durig M, Harder F, Di Padova C, Zanussi C. Impaired antipneumococcal antibody production in patients without spleens. Br Med J 1985;290:14-6.","journal-title":"Br Med J"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jcp.25.4.326","article-title":"An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload","volume":"25","author":"Addison, G.M.; Beamish, M.R.; Hales, C.N.; Hodgkins, M.; Jacobs, A.; Llewellyn, P.","year":"1972","unstructured":"Addison GM, Beamish MR, Hales CN, Hodgkins M, Jacobs A, Llewellyn P. An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. J Clin Pathol 1972;25:326-9.","journal-title":"J Clin Pathol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/jcp.40.11.1353","article-title":"Hepatitis pathology in regularly transfused, B thalassaemia major patients on long term subcutaneous desferrioxamine therapy: the role of parentally transmitted hepatitis","volume":"40","author":"Aldouri, M.A.; Wonke, B.; Hoffbrand, V.","year":"1987","unstructured":"Aldouri MA, Wonke B, Hoffbrand V, et al. Hepatitis pathology in regularly transfused,B thalassaemia major patients on long term subcutaneous desferrioxamine therapy: the role of parentally transmitted hepatitis. J Clin Pathol 1987;40:1353-9.","journal-title":"J Clin Pathol"},{"key":"ref_22","first-page":"383","article-title":"Transfusion-transmitted viruses: interim analysis of hepatitis among transfused and non-transfused patients","author":"Aach, R.D.; Lander, J.J.; Sherman, L.A.","year":"1978","unstructured":"Aach RD, Lander JJ, Sherman LA, et al. Transfusion-transmitted viruses: interim analysis of hepatitis among transfused and non-transfused patients. In: Vyas GN, Cohen SN, Schmid R, eds. Viral hepatitis. San Francisco: Franklin Institute Press, 1978:383-96."},{"key":"ref_23","series-title":"Proceedings of hepatitis workshop, Stirling. Edinburgh: Nuclear Enterprises","first-page":"31","article-title":"Post-transfusion hepatitis in north London in 1981: a review including a case of hepatitis","author":"Barbara, J.A.J.; Briggs, M.","year":"1982","unstructured":"Barbara JAJ, Briggs M. Post-transfusion hepatitis in north London in 1981: a review including a case of hepatitis A. In: Hopkins R, Field SE, eds. Proceedings of hepatitis workshop, Stirling. Edinburgh: Nuclear Enterprises, 1982:31-5."},{"key":"ref_24","first-page":"40","article-title":"Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association","volume":"24","author":"Szmuness, W.","year":"1978","unstructured":"Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 1978;24:40-69.","journal-title":"Prog Med Virol"},{"key":"ref_25","first-page":"1129","article-title":"Hepatocellular carcinoma and hepatitis B virus","volume":"ii:","author":"Beasley, R.P.; Hwang, L.Y.; Lin, C.C.; Chien, C.S.","year":"1981","unstructured":"Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. Lancet 1981;ii:1129-33.","journal-title":"Lancet"},{"key":"ref_26","first-page":"21","article-title":"Hepatitis B virus as the etiological agent in hepatocellular carcinoma-epidemiological considerations","volume":"2","author":"Beasley, R.P.","year":"1982","unstructured":"Beasley RP. Hepatitis B virus as the etiological agent in hepatocellular carcinoma-epidemiological considerations. Hepatology 1982;2:21-68.","journal-title":"Hepatology"},{"key":"ref_27","first-page":"607","article-title":"hepatocellular carcinoma, and strategies for prevention","volume":"i:","author":"Arthur, M.J.P.; Hall, A.J.; Hepatitis, Wright R.; B.","year":"1984","unstructured":"Arthur MJP, Hall AJ, Wright R. Hepatitis B, hepatocellular carcinoma, and strategies for prevention. Lancet 1984;i:607-10.","journal-title":"Lancet"},{"key":"ref_28","first-page":"209","article-title":"Epidemiology of hepatocellular carcinoma","volume-title":"hepatitis and liver disease","author":"Beasley, R.P.; Hwang, L.Y.","year":"1984","unstructured":"Beasley RP, Hwang LY. Epidemiology of hepatocellular carcinoma. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral hepatitis and liver disease. Orlando: Grune and Stratton, 1984:209-24."},{"key":"ref_29","first-page":"37","article-title":"Mortality of hepatitis B positive blood donors in England and Wales. Lancet 1985; i: 91-3. 3' Polakoff S. Acute viral hepatitis B. Laboratory reports 1980-84","volume":"293","author":"Hall, A.J.; Winter, P.D.; Wright, R.","year":"1986","unstructured":"Hall AJ, Winter PD, Wright R. Mortality of hepatitis B positive blood donors in England and Wales. Lancet 1985;i:91-3. 3' Polakoff S. Acute viral hepatitis B. Laboratory reports 1980-84. Br Med J 1986;293:37-8.","journal-title":"Br Med J"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/bmj.294.6566.197","article-title":"Time for action on hepatitis B immunisation","volume":"294","author":"Finch, R.","year":"1987","unstructured":"Finch R. Time for action on hepatitis B immunisation. Br Med J 1987;294:197-8.","journal-title":"Br Med J"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jmv.1890060407","article-title":"Contrasting patterns and frequency of antibodies to the surface, core and envelope antigens of hepatitis B virus in blood donors and in homosexual patients","volume":"6","author":"Tedder, R.S.; Cameron, C.H.; Wilson-Croome, R.; Howell, D.R.; Colgrove, A.; Barbara, J.A.J.","year":"1980","unstructured":"Tedder RS, Cameron CH, Wilson-Croome R, Howell DR, Colgrove A, Barbara JAJ. Contrasting patterns and frequency of antibodies to the surface, core and envelope antigens of hepatitis B virus in blood donors and in homosexual patients. J Med Virol 1980;6:323-32.","journal-title":"J Med Virol"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJM197806222982502","article-title":"Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen","volume":"298","author":"Hoofnagle, J.H.; Seeff, L.B.; Bales, Z.B.","year":"1978","unstructured":"Hoofnagle JH, Seeff LB, Bales ZB, et al. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978;298:1379-83.","journal-title":"N Engl J Med"},{"key":"ref_33","first-page":"1422","article-title":"Anti-HBc and blood infectivity","volume":"298","author":"Katchaki, J.N.; Bronwer, R.; Siem, T.H.","year":"1978","unstructured":"Katchaki JN, Bronwer R, Siem TH. Anti-HBc and blood infectivity. N Engl J Med 1978;298:1422.","journal-title":"N Engl J Med"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198607243150401","article-title":"Long term immunogenicity and efficacy of hepatitis B vaccine in homosexual men","volume":"315","author":"Hadler, S.C.; Francis, D.P.; Maynard, J.F.","year":"1986","unstructured":"Hadler SC, Francis DP, Maynard JF, et al. Long term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315:209-14.","journal-title":"N Engl J Med"},{"issue":"1","key":"ref_35","first-page":"12","article-title":"Passive active immunisation against hepatitis B","volume":"150","author":"Zachoval, R.; Jilg, W.; Lorbeer, B.; Schmidt, M.; Deinhardt, F.","year":"1984","unstructured":"Zachoval R, Jilg W, Lorbeer B, Schmidt M, Deinhardt F. Passive active immunisation against hepatitis B. J Infect Dis 1984;150:1 12-7.","journal-title":"J Infect Dis"},{"key":"ref_36","first-page":"458","article-title":"Hepatitis B vaccination: how long does protection last?","volume":"ii:","author":"Jilg, W.; Schmidt, M.; Deinhardt, F.; Zachoral, R.","year":"1984","unstructured":"Jilg W, Schmidt M, Deinhardt F, Zachoral R. Hepatitis B vaccination: how long does protection last? Lancet 1984;ii:458.","journal-title":"Lancet"},{"key":"ref_37","first-page":"983","article-title":"Persistence of antiHBs after intradermal inoculation of reduced doses of hepatitis B vaccine","volume":"ii:","author":"Zoulek, G.; Lorbeer, B.; Jilg, W.; Deinhardt, F.","year":"1984","unstructured":"Zoulek G, Lorbeer B, Jilg W, Deinhardt F. Persistence of antiHBs after intradermal inoculation of reduced doses of hepatitis B vaccine. Lancet 1984;ii:983-4.","journal-title":"Lancet"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.64.4.535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T03:49:22Z","timestamp":1684813762000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/adc.64.4.535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,4,1]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/adc.64.4.535","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,4,1]]}}}